Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 16 (RPL15P16) is a processed pseudogene and not a functional protein-coding gene. Pseudogenes are genomic DNA sequences similar to normal genes but non-functional; they are typically the result of gene duplication or retrotransposition events and have accumulated mutations that preclude normal protein production. RPL15P16 is related by sequence homology to the functional ribosomal protein L15 gene (RPL15), which encodes a critical structural protein of the large 60S ribosomal subunit involved in translation. However, RPL15P16 itself does not encode a functional protein, has no known biological function, is not associated with disease, and is not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 16 (RPL15P16).